Sign inGet started

GAY ROBERT C

Insider CIK 1032566 · MACK Director · ANGX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANGX Angel Studios, Inc. M Exercise deriv2026-10-262026-10-272,649— —0SEC↗
ANGX Angel Studios, Inc. M Exercise2026-10-262026-10-272,649— —10,593SEC↗
ANGX Angel Studios, Inc. M Exercise deriv2026-07-232026-07-242,648— $02,649SEC↗
ANGX Angel Studios, Inc. M Exercise2026-07-232026-07-242,648— $07,944SEC↗
ANGX Angel Studios, Inc. M Exercise deriv2026-05-222026-05-265,296— $05,297SEC↗
ANGX Angel Studios, Inc. M Exercise2026-05-222026-05-265,296— $05,296SEC↗
ANGX Angel Studios, Inc. A Award deriv2025-10-232025-10-2810,593— $010,593SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion deriv2012-04-032012-04-05113,586— $00SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion deriv2012-04-032012-04-05142,857— $00SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion deriv2012-04-032012-04-05142,857— $00SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion deriv2012-04-032012-04-05113,586— $00SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion2012-04-032012-04-05175,316— $0175,316SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion2012-04-032012-04-05142,857— $0636,346SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion2012-04-032012-04-05142,857— $0318,173SEC↗
MACK MERRIMACK PHARMACEUTICALS C Conversion2012-04-032012-04-05175,316— $0493,489SEC↗